Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
April 30, 2000
Conditions
Cancer
Interventions
DRUG
floxuridine
DRUG
leucovorin calcium
DRUG
oxaliplatin
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00005860 - Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | Biotech Hunter | Biotech Hunter